Web Content Viewer - Fixed Context

Policy title: Computer-Assisted Corneal Topography

Policy number: MA 5.062

Clinical benefit

  • Minimize safety risk or concern.
  • Minimize harmful or ineffective interventions.
  • Assure appropriate level of care.
  • Assure appropriate duration of service for interventions.
  • Assure that recommended medical prerequisites have been met.
  • Assure appropriate site of treatment or service.

Effective date: 4/1/2026

Policy

Computer-assisted corneal topography is considered medically necessary for any of the following indications:

  • Pre-operative evaluation for phototherapeutic keratectomy.
  • Pre-operative evaluation for surgery to correct astigmatism resulting from trauma or from previous surgery.
  • Assessment of post-operative complications associated with post-traumatic corneal scarring or complications of a transplanted cornea.
  • Post-operative management of penetrating keratoplasty or cataract surgery.
  • Documenting visual complications resulting from trauma or from previous surgery.
  • Evaluation of patients with unexplained visual loss.
  • Diagnosis and management of keratoconus, bullous keratopathy, or corneal dystrophy

Computer-assisted corneal topography is considered investigational for all other indications including when performed as part of pre-operative assessment of members with cataracts. There is insufficient evidence to support a general conclusion concerning the health outcomes or benefits associated with this procedure.

This medical policy applies to Medicare Advantage plans offered by Capital Blue Cross and its subsidiaries.

Description/Background

Corneal topography describes measurements of the curvature of the cornea. An evaluation of corneal topography is necessary for the accurate diagnosis and follow-up of certain corneal disorders, such as keratoconus, difficult contact lens fits, and pre- and postoperative assessment of the cornea, most commonly after refractive surgery.

Assessing corneal topography is part of the standard ophthalmologic examination of some patients. Corneal topography can be evaluated and determined in multiple ways. Computer-assisted corneal topography has been used for early identification and quantitative documentation of the progression of keratoconic corneas, and evidence is sufficient to indicate that computer-assisted topographic mapping can detect and monitor disease.

Various techniques and instruments are available to measure corneal topography: keratometer, keratoscope, and computer-assisted photokeratoscopy.

The keratometer (also referred to as an ophthalmometer), the most commonly used instrument, projects an illuminated image onto a central area in the cornea. By measuring the distance between a pair of reflected points in both of the cornea’s 2 principal meridians, the keratometer can estimate the radius of curvature of 2 meridians. Limitations of this technique include the fact that the keratometer can only estimate the corneal curvature over a small percentage of its surface and that estimates are based on the frequently incorrect assumption that the cornea is spherical.

The keratoscope reflects a series of concentric circular rings off the anterior corneal surface. Visual inspection of the shape and spacing of the concentric rings provides a qualitative assessment of topography.

A photokeratoscope is a keratoscope equipped with a camera that can provide a permanent record of the corneal topography. Computer-assisted photokeratoscopy is an alternative to keratometry or keratoscopy for measuring corneal curvature. This technique uses sophisticated image analysis programs to provide quantitative corneal topographic data. Early computer-based programs were combined with keratoscopy to create graphic displays and high-resolution, color-coded maps of the corneal surface. Newer technologies measure both curvature and shape, enabling quantitative assessment of corneal depth, elevation, and power.

Regulatory Status

A number of corneal topography devices have been cleared for marketing by the U.S. Food and Drug Administration (FDA) through the 510(k) process (Table 1). In 1999, the Orbscan® (manufactured by Orbtek, distributed by Bausch and Lomb) was cleared by the FDA. The second-generation Orbscan II is a hybrid system that uses both projective (slit scanning) and reflective (Placido) methods. The Pentacam® (Oculus) is 1 of a number of rotating Scheimpflug imaging systems produced in Germany. In 2005, the Pentacam HR was released with a newly designed high-resolution camera and improved optics.

Rationale

Summary of Evidence

For individuals who have disorders of corneal topography who receive computer-assisted corneal topography/photokeratoscopy, the evidence includes a single RCT and multiple nonrandomized studies. Relevant outcomes are test accuracy, other test performance measures, and functional outcomes. With the exception of refractive surgery, a procedure not discussed herein, no studies have shown clinical benefit (eg, a change in treatment decisions) based on a quantitative evaluation of corneal topography. In addition, a large prospective series found no advantage with use of different computer-assisted corneal topography methods over manual corneal keratometry. Computer-assisted corneal topography lacks evidence from appropriately constructed clinical trials that could confirm whether it improves outcomes. The evidence is sufficient to determine that the technology results in an improvement in the net health outcome.

Definitions

NA

Disclaimer

Capital Blue Cross’ medical policies are used to determine coverage for specific medical technologies, procedures, equipment, and services. These medical policies do not constitute medical advice and are subject to change as permitted by law or applicable clinical evidence from independent treatment guidelines. Treating providers are solely responsible for medical advice and treatment of members. These polices are not a guarantee of coverage or payment. Payment of claims is subject to a determination regarding the member’s benefit program and eligibility on the date of service, and a determination that the services are medically necessary and appropriate. Final processing of a claim is based upon the terms of contract that applies to the members’ benefit program, including benefit limitations and exclusions. If a provider or a member has a question concerning this medical policy, please contact Capital Blue Cross’ Provider Services or Member Services.

Coding information

Note: This list of codes is not exhaustive and may change from time to time as permitted by law or applicable clinical guidelines. The inclusion of a code in this section is not a guarantee of coverage or payment. In addition, not all covered services are eligible for separate reimbursement.

Medically Necessary

Procedure Codes

92025

 

 

 

 

Medically Necessary Diagnoses for Corneal Topography

ICD-10-CM Diagnosis Codes
Description

A18.59

Other tuberculosis of eye

E36.8

Other intraoperative complications of endocrine system

H17.00

Adherent leukoma, unspecified eye

H17.01

Adherent leukoma, right eye

H17.02

Adherent leukoma, left eye

H17.03

Adherent leukoma, bilateral

H17.10

Central corneal opacity, unspecified eye

H17.11

Central corneal opacity, right eye

H17.12

Central corneal opacity, left eye

H17.13

Central corneal opacity, bilateral

H17.811

Minor opacity of cornea, right eye

H17.812

Minor opacity of cornea, left eye

H17.813

Minor opacity of cornea, bilateral

H17.819

Minor opacity of cornea, unspecified eye

H17.821

Peripheral opacity of cornea, right eye

H17.822

Peripheral opacity of cornea, left eye

H17.823

Peripheral opacity of cornea, bilateral

H17.829

Peripheral opacity of cornea, unspecified eye

H17.89

Other corneal scars and opacities

H17.9

Unspecified corneal scar and opacity

H18.10

Bullous keratopathy, unspecified eye

H18.11

Bullous keratopathy, right eye

H18.12

Bullous keratopathy, left eye

H18.13

Bullous keratopathy, bilateral

H18.501

Unspecified hereditary corneal dystrophies, right eye

H18.502

Unspecified hereditary corneal dystrophies, left eye

H18.503

Unspecified hereditary corneal dystrophies, bilateral

H18.509

Unspecified hereditary corneal dystrophies, unspecified eye

H18.511

Endothelial corneal dystrophy, right eye

H18.512

Endothelial corneal dystrophy, left eye

H18.513

Endothelial corneal dystrophy, bilateral

H15.519

Endothelial corneal dystrophy, unspecified eye

H18.521

Epithelial (juvenile) corneal dystrophy, right eye

H18.522

Epithelial (juvenile) corneal dystrophy, left eye

H18.523

Epithelial (juvenile) corneal dystrophy, bilateral

H18.529

Epithelial (juvenile) corneal dystrophy, unspecified eye

H18.531

Granular corneal dystrophy, right eye

H18.532

Granular corneal dystrophy, left eye

H18.533

Granular corneal dystrophy, bilateral

H18.539

Granular corneal dystrophy, unspecified eye

H18.541

Lattice corneal dystrophy, right eye

H18.542

Lattice corneal dystrophy, left eye

H18.543

Lattice corneal dystrophy, bilateral

H18.549

Lattice corneal dystrophy, unspecified eye

H18.551

Macular corneal dystrophy, right eye

H18.552

Macular corneal dystrophy, left eye

H18.553

Macular corneal dystrophy, bilateral

H18.559

Macular corneal dystrophy, unspecified eye

H18.591

Other hereditary corneal dystrophies, right eye

H18.592

Other hereditary corneal dystrophies, left eye

H18.593

Other hereditary corneal dystrophies, bilateral

H18.599

Other hereditary corneal dystrophies, unspecified eye

H18.601

Keratoconus, unspecified, right eye

H18.602

Keratoconus, unspecified, left eye

H18.603

Keratoconus, unspecified, bilateral

H18.609

Keratoconus, unspecified, unspecified eye

H18.611

Keratoconus, stable, right eye

H18.612

Keratoconus, stable, left eye

H18.613

Keratoconus, stable, bilateral

H18.619

Keratoconus, stable, unspecified eye

H18.621

Keratoconus, unstable, right eye

H18.622

Keratoconus, unstable, left eye

H18.623

Keratoconus, unstable, bilateral

H18.629

Keratoconus, unstable, unspecified eye

H18.711

Corneal ectasia, right eye

H18.712

Corneal ectasia, left eye

H18.713

Corneal ectasia, bilateral

H18.719

Corneal ectasia, unspecified eye

H18.899

Other specified disorders of cornea, unspecified eye

H18.9

Unspecified disorder of cornea

H27.00

Aphakia, unspecified eye

H27.01

Aphakia, right eye

H27.02

Aphakia, left eye

H27.03

Aphakia, bilateral

H52.201

Unspecified astigmatism, right eye

H52.202

Unspecified astigmatism, left eye

H52.203

Unspecified astigmatism, bilateral

H52.209

Unspecified astigmatism, unspecified eye

H52.211

Irregular astigmatism, right eye

H52.212

Irregular astigmatism, left eye

H52.213

Irregular astigmatism, bilateral

H52.219

Irregular astigmatism, unspecified eye

H52.221

Regular astigmatism, right eye

H52.222

Regular astigmatism, left eye

H52.223

Regular astigmatism, bilateral

H52.229

Regular astigmatism, unspecified eye

L76.81

Other intraoperative complications of skin and subcutaneous tissue

L76.82

Other postprocedural complications of skin and subcutaneous tissue

Q12.3

Congenital aphakia

S05.00XA

Injury of conjunctiva and corneal abrasion without foreign body, unspecified eye, initial encounter

S05.00XD

Injury of conjunctiva and corneal abrasion without foreign body, unspecified eye, subsequent encounter

S05.00XS

Injury of conjunctiva and corneal abrasion without foreign body, unspecified eye, sequela

S05.01XA

Injury of conjunctiva and corneal abrasion without foreign body, right eye, initial encounter

S05.01XD

Injury of conjunctiva and corneal abrasion without foreign body, right eye, subsequent encounter

S05.01XS

Injury of conjunctiva and corneal abrasion without foreign body, right eye, sequela

S05.02XA

Injury of conjunctiva and corneal abrasion without foreign body, left eye, initial encounter

S05.02XD

Injury of conjunctiva and corneal abrasion without foreign body, left eye, subsequent encounter

S05.02XS

Injury of conjunctiva and corneal abrasion without foreign body, left eye, sequela

S05.8X1A

Other injuries of right eye and orbit, initial encounter

S05.8X1D

Other injuries of right eye and orbit, subsequent encounter

S05.8X1S

Other injuries of right eye and orbit, sequela

S05.8X2A

Other injuries of left eye and orbit, initial encounter

S05.8X2D

Other injuries of left eye and orbit, subsequent encounter

S05.8X2S

Other injuries of left right eye and orbit, sequela

T81.31XA

Disruption of external operation (surgical) wound, not elsewhere classified, initial encounter

T81.31XD

Disruption of external operation (surgical) wound, not elsewhere classified, subsequent encounter

T81.31XS

Disruption of external operation (surgical) wound, not elsewhere classified, sequela

T81.49XA

Infection following a procedure, other surgical site, initial encounter

T81.49XD

Infection following a procedure, other surgical site, subsequent encounter

T81.49XS

Infection following a procedure, other surgical site, sequela

T81.89XA

Other complications of procedures, not elsewhere classified, initial encounter

T81.89XD

Other complications of procedures, not elsewhere classified, subsequent encounter

T86.840

Corneal transplant rejection

T86.841

Corneal transplant failure

T86.842

Corneal transplant infection

T86.848

Other complications of corneal transplant

T86.849

Unspecified complication of corneal transplant

Z94.7

Corneal transplant status

References

  1. Morrow GL, Stein RM. Evaluation of corneal topography: past, present, and future trends. Can J Ophthalmol. Aug 1992; 27(5):213-225. PMID 1393805.

  2. Wilson SE, Klyce SD. Advances in the analysis of corneal topography. Surv Ophthalmol. Jan-Feb 1991; 35(4):269-277. PMID 2011820.

  3. Martinez-Abad A, Pinero DP, Ruiz-Fortes P, et al. Evaluation of the diagnostic ability of vector parameters characterizing the corneal astigmatism and regularity in clinical and subclinical keratoconus. Cont Lens Anterior Eye. Apr 2017; 40(2):88-96. PMID 27931882.

  4. Weber SL, Ambrosio R, Jr., Lipener C, et al. The use of ocular anatomical measurements using a rotating Scheimpflug camera to assist in the Esclera(R) scleral contact lens fitting process. Cont Lens Anterior Eye. Apr 2016; 39(2):148-153. PMID 26474924.

  5. Bhatoa NS, Hau S, Ehrlich DP. A comparison of a topography-based rigid gas permeable contact lens design with a conventionally fitted lens in patients with keratoconus. Cont Lens Anterior Eye. Jun 2010; 33(3):128-135. PMID 20053579.

  6. DeNaeyer G, Sanders DR, Farajian TS. Surface coverage with single vs. multiple gaze surface topography to fit scleral lenses. Cont Lens Anterior Eye. Jun 2017; 40(3):162-169. PMID 28336224.

  7. Bandlitz S, Baumer J, Conrad U, et al. Scleral topography analysed by optical coherence tomography. Cont Lens Anterior Eye. Aug 2017; 40(4):242-247. PMID 28495356.

  8. Lee H, Chung JL, Kim EK, et al. Univariate and bivariate polar value analysis of corneal astigmatism measurements obtained with 6 instruments. J Cataract Refract Surg. Sep 2012; 38(9):1608-1615. PMID 22795977.

  9. de Sanctis U, Donna P, Penna RR, et al. Corneal astigmatism measurement by ray tracing versus anterior surface-based keratometry in candidates for toric intraocular lens implantation. Am J Ophthalmol. May 2017; 177:1-8. PMID 28185842.

  10. Ophthalmic Technology Assessment Committee Cornea Panel American Academy of Ophthalmology. Corneal topography. American Academy of Ophthalmology. Ophthalmology. Aug 1999; 106(8):1628-1638. PMID 10442914.

  11. American Academy of Ophthalmology (AAO). Refractive Surgery Preferred Practice Pattern®. 2022.

  12. Fan R, Chan TC, Prakash G, Jhanji V. Applications of corneal topography and tomography: a review. Clin Exp Ophthalmol. 2018; 46(2):133-146. doi:10.1111/ceo.13136. PMID 29266624.

  13. Lambert SR, Kraker RT, Pineles SL, et al. Contact Lens Correction of Aphakia in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2018; 125(9):1452-1458. doi:10.1016/j.ophtha.2018.03.014.

Policy history

  • MA 5.062
    • 04/01/2026 Policy creation.

Plans issued by Capital Blue Cross and it’s subsidiaries are independent licensees of the Blue Cross Blue Shield Association. Communications issued by Capital Blue Cross in its capacity as administrator of programs and provider relations for all companies.

Web Content Viewer - Fixed Context

Updated January 1, 2026

Y0016_26WBST_M